Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 89

Sort by

Sort Order Select

Journal Articles

Incidence of VTE Among Patients with a Cancer Diagnosis in Oklahoma County

Micah Denay McCumber, BS, MS, Aaron Mark Wendelboe, PhD MS, Janis Campbell, PhD GISP, Kai Ding, PhD, Michele G Beckman, MPH, Nimia L Reyes, MD MPH, Gary E. Raskob, PhD

Blood (2019) 134 (Supplement_1): 3463.

https://doi.org/10.1182/blood-2019-130604

Published: 2019

Journal Articles

Fibrin As a Target for Glioblastoma Detection and Treatment

Lynn M Knowles, PhD, Carolin Wolter, MS, Ralf Ketter, MD, Steffi Urbschat, PhD, Stefan Linsler, MD, Simon Müller, MD, Andreas Müller, PhD, Hermann Eichler, Jan Pilch, MD

Blood (2019) 134 (Supplement_1): 3630.

https://doi.org/10.1182/blood-2019-124089

Published: 2019

Journal Articles

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2019) 134 (Supplement_1): 2438.

https://doi.org/10.1182/blood-2019-126027

Published: 2019

Journal Articles

Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The RaDD Study

Eliza A Hawkes, Kate Manos, Geoff Chong, Jodie Palmer, Michael MacManus, Colm Keane, MD, Andrew Scott, Jake Shortt, MBBS FRACP FRCPA PhD, David Ritchie, MD PhD, Leonid Churilov, Laura Johnston, Tom Witkowski, Allison Barraclough, Sze-Ting Lee, Wendi Lin, Rachel Koldej, Richard Khor

Blood (2019) 134 (Supplement_1): 5328.

https://doi.org/10.1182/blood-2019-122635

Published: 2019

Journal Articles

AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Eliza A Hawkes, Kate Manos, MBBS, Charmaine Smith, Joanne Hawking, Stephanie O'Brien, Leonid Churilov, Joseph McKendrick, William Renwick, Andrew Grigg, Tom Witkowski, Andrew Scott, Sze-Ting Lee, Wendi Lin, Chun Fong, Carmela Rooney, Allison Barraclough, Joel Wight, Geoff Chong

Blood (2019) 134 (Supplement_1): 5332.

https://doi.org/10.1182/blood-2019-127858

Published: 2019

Journal Articles

Safety of Doacs in Patients with CNS Malignancies

Andrew Swartz, MD, Jan Drappatz

Blood (2019) 134 (Supplement_1): 1160.

https://doi.org/10.1182/blood-2019-125161

Published: 2019

Journal Articles

Treatment‐Related Acute Myeloid Leukemia in Children

Katharina Waack, Katharina Röllecke, PhD, Mareike Rasche, MD, Christiane Walter, MSc, Ursula Creutzig, MD PhD, Dirk Reinhardt, MD PhD

Blood (2019) 134 (Supplement_1): 1322.

https://doi.org/10.1182/blood-2019-131911

Published: 2019

Journal Articles

Low Molecular Weight Heparin (LMWH) for Venous Thromboembolism (VTE) Prophylaxis in Patients with Primary Central Nervous System Lymphoma (PCNSL)

Deborah Rund, MD, Stav Gazal, BSc, Yosef Kalish, MD, Chen Makranz, MD, Neta Goldschmidt, MD

Blood (2018) 132 (Supplement 1): 2993.

https://doi.org/10.1182/blood-2018-99-119154

Published: 2018

Journal Articles

Dose Reduction of First and Second Generation TKIs Is Effective in the Maintenance of Major Molecular Response and May Predict Successful Tfr in CML Patients

Simone Claudiani, MD, Jane Apperley, MB ChB MD, Afzal Khan, Richard Szydlo, PhD, George Nesr, MD, George Adams, MBChB, Letizia Foroni, MD PhD, Jamshid S Khorashad, MD PhD, Dragana Milojkovic, MBBS, PhD

Blood (2018) 132 (Supplement 1): 3007.

https://doi.org/10.1182/blood-2018-99-119602

Published: 2018

Journal Articles

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2018) 132 (Supplement 1): 2521.

https://doi.org/10.1182/blood-2018-99-115666

Published: 2018

Journal Articles

Oncolytics Virus Replication Using Pelareorep (Reolysin) and Carfilzomib in Relapsed Myeloma Patients Increases PD-L1 Expression with Clinical Responses

Craig C Hofmeister, MDMPH, Douglas W. Sborov, MD MS, Domenico Viola, Ada Dona, Gerald J Nuovo, PhD, Don M. Benson, Jr., MD PhD, Sagar Lonial, MD, Jonathan L Kaufman, MD, Ajay K Nooka, MD MPH, Leonard Heffner, MD, Madhav V Dhodapkar, MD, Flavia Pichiorri, PhD

Blood (2018) 132 (Supplement 1): 2655.

https://doi.org/10.1182/blood-2018-99-113500

Published: 2018

Journal Articles

Bleeding Risk of Low-Molecular Weight Heparin Vs Direct Oral Anticoagulant in Patients with Intracranial Tumors

R Sumner Abraham, IV, MD, Trish A Millard, MD, Surabhi Palkimas, PharmD, Nolan A Wages, PhD, Hillary S. Maitland, MD MS

Blood (2018) 132 (Supplement 1): 2524.

https://doi.org/10.1182/blood-2018-99-113949

Published: 2018

Journal Articles

Increased Health Care Cost Associated with Venous Thromboembolism in Patients with Malignant Glioma

Heather Wright, DO, Chris E. Holmes, MD PhD, Alissa Thomas, MD

Blood (2018) 132 (Supplement 1): 3524.

https://doi.org/10.1182/blood-2018-99-120009

Published: 2018

Journal Articles

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Jason R Schwartz, MD PhD, Michael P Walsh, PhD, Jing Ma, PhD, Tamara Lamprecht, B.S., Raul C Ribeiro, MD, Jeffery M. Klco, MD PhD

Blood (2018) 132 (Supplement 1): 2775.

https://doi.org/10.1182/blood-2018-99-118995

Published: 2018

Journal Articles

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

Andrea Sitlinger, MD, Dana P Thompson, PhD, Michael A Deal, BS, Erwin Garcia, PhD, Tiffany Stewart, BS, Eross Guadalupe, BS, J. Brice Weinberg, MD, David A Bartlett, PhD, Danielle M. Brander, MD

Blood (2018) 132 (Supplement 1): 5540.

https://doi.org/10.1182/blood-2018-99-117736

Published: 2018

Journal Articles

Mll -Partial Tandem Duplication ( Mll -PTD) Causes Pseudohypoxia and Hypermethylation of the Epigenome through Suppression of Mitochondrial Complex II

Asumi Yokota, PhD, Lulu Zhang, PhD, Xiaomei Yan, MD PhD, Xiaomin Feng, MD PhD, Lijun Wen, MS, George Freudiger, Maria Rife, Ally Woeste, Yoshihiro Hayashi, MD PhD, Gang Huang, PhD

Blood (2018) 132 (Supplement 1): 1311.

https://doi.org/10.1182/blood-2018-99-112529

Published: 2018

Journal Articles

Inherited Disorders of the Ras-MAPK Pathway

Christian P. Kratz, MD, Martin Zenker, MD

Blood (2018) 132 (Supplement 1): SCI-41.

https://doi.org/10.1182/blood-2018-99-109379

Published: 2018

Journal Articles

Enhanced Expression of FGF Signaling in Primary Central Nervous System Lymphoma

Alanna Maguire, PhD MSc, Talal Hilal, MBBChir, Xianfeng Chen, BSc, Allison C. Rosenthal, DO, Lisa M. Rimsza, MD

Blood (2018) 132 (Supplement 1): 2847.

https://doi.org/10.1182/blood-2018-99-116416

Published: 2018

Journal Articles

Podoplanin Expression in the Bleeding Complications of Acute Promyelocytic Leukemias

Vincent-Philippe Lavallee, MD, Jalila Chagraoui, PhD, MacRae Tara, M.Sc., Miriam Marquis, PhD, Bonnefoy Arnaud, PhD, Jana Krosl, PhD, Sébastien Lemieux, PhD, Georges-Étienne Rivard, MD, Josée Hébert, MD, Guy Sauvageau, MD, PhD

Blood (2017) 130 (Supplement 1): 105.

https://doi.org/10.1182/blood.V130.Suppl_1.105.105

Published: 2017

Journal Articles

Clinical Relevance of Intracranial Hemorrhage Volume in Primary and Metastatic Brain Tumors

Mohana Roy, MD, Charlene Mantia, MD, Erik J Uhlmann, MD, Maneka Puligandla, MS, Griffin Weber, MD PhD, Donna S. Neuberg, ScD, Jeffrey I Zwicker, MD

Blood (2017) 130 (Supplement 1): 2388.

https://doi.org/10.1182/blood.V130.Suppl_1.2388.2388

Published: 2017

NARROW

Incidence of VTE Among Patients with a Cancer Diagnosis in Oklahoma County

Fibrin As a Target for Glioblastoma Detection and Treatment

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The RaDD Study

AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Safety of Doacs in Patients with CNS Malignancies

Treatment‐Related Acute Myeloid Leukemia in Children

Low Molecular Weight Heparin (LMWH) for Venous Thromboembolism (VTE) Prophylaxis in Patients with Primary Central Nervous System Lymphoma (PCNSL)

Dose Reduction of First and Second Generation TKIs Is Effective in the Maintenance of Major Molecular Response and May Predict Successful Tfr in CML Patients

Safety of Direct-Acting Oral Anticoagulants Versus Enoxaparin in Patients with Primary and Metastatic Brain Tumors

Oncolytics Virus Replication Using Pelareorep (Reolysin) and Carfilzomib in Relapsed Myeloma Patients Increases PD-L1 Expression with Clinical Responses

Bleeding Risk of Low-Molecular Weight Heparin Vs Direct Oral Anticoagulant in Patients with Intracranial Tumors

Increased Health Care Cost Associated with Venous Thromboembolism in Patients with Malignant Glioma

The Mutational Profile of Pediatric Therapy-Related Myeloid Neoplasms

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

Mll -Partial Tandem Duplication ( Mll -PTD) Causes Pseudohypoxia and Hypermethylation of the Epigenome through Suppression of Mitochondrial Complex II

Inherited Disorders of the Ras-MAPK Pathway

Enhanced Expression of FGF Signaling in Primary Central Nervous System Lymphoma

Podoplanin Expression in the Bleeding Complications of Acute Promyelocytic Leukemias

Clinical Relevance of Intracranial Hemorrhage Volume in Primary and Metastatic Brain Tumors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only